Proterris Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A
- (Cancelled)
- Latest Deal Amount
-
$22.5M
- Investors
-
5
Proterris General Information
Description
Operator of a clinical-stage firm designed to focus on therapeutic uses of inhaled and small-molecule carbon monoxide. The company focuses on inhaled carbon monoxide and carbon monoxide-releasing molecules that cover a wide range of fibrotic, transplantation, other ischemia-reperfusion injury and anti-inflammatory disorders, enabling patients to avail carbon monoxide for delayed graft function in renal transplant recipients and idiopathic pulmonary fibrosis (IPF).
Contact Information
Website
www.proterris.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Therapeutic Devices
Primary Office
- Care of Apeiron Partners
- 33 Broad Street
- Boston, MA 02109
- United States
Proterris Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 01-Nov-2019 | $22.5M | Cancelled | Clinical Trials - Phase 2 | ||
| 4. Later Stage VC (Series A) | 16-Aug-2019 | 000 | 000 | 0000 | Completed | Clinical Trials - Phase 2 |
| 3. Early Stage VC (Series A) | 31-Dec-2017 | Completed | Startup | |||
| 2. Grant | $22.7M | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Proterris Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.00 |
Proterris Patents
Proterris Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3643176-A1 | Systems and methods to improve organ or tissue function and organ or tissue transplant longevity | Pending | 15-Apr-2014 | 000000000 | 0 |
| EP-3131401-A4 | Systems and methods to improve organ or tissue function and organ or tissue transplant longevity | Active | 15-Apr-2014 | 000000000 | 0 |
| US-20180000859-A1 | Systems andmethods to improve organor tissue function andorganor tissue transplant longevity | Active | 15-Apr-2014 | 000000000 | |
| US-20210308175-A1 | Systems and methods to improve organ or tissue function and organ or tissue transplant longevity | Pending | 15-Apr-2014 | 000000000 | |
| US-9789133-B2 | Systems and methods to improve organ or tissue function and organ or tissue transplant longevity | Active | 15-Apr-2014 | A61K33/00 |
Proterris Executive Team (7)
Proterris Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Donald DeBethizy Ph.D | Self | Board Member | 000 0000 |
| Jeffrey Wager MD | Self | Co-Founder, Chief Executive Officer & Chairman | 000 0000 |
| Matthew Bennett JD | Self | Board Member | 000 0000 |
| Peter Hutt JD | Self | Board Member | 000 0000 |
Proterris Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Proterris Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Columbia Technology Ventures | University | Minority | 000 0000 | 000000 0 | |
| Portugal Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| The Starr Foundation | Other | Minority | 000 0000 | 000000 0 | |
| Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 |
Proterris Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 | 31-Dec-2017 | 0000000000 | Drug Discovery | 0000000 0 |